Search

Your search keyword '"Ma, Yussanne"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Ma, Yussanne" Remove constraint Author: "Ma, Yussanne" Database ScienceDirect Remove constraint Database: ScienceDirect
26 results on '"Ma, Yussanne"'

Search Results

1. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

2. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

3. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

4. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

5. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

6. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

7. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

8. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

9. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

10. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

11. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

12. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype

14. CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML

15. Integrative genomic analysis of ghost cell odontogenic carcinoma

16. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

18. Burkitt Lymphoma Genome Sequencing Project (BLGSP): Integrative Genomic and Transcriptomic Characterization of Burkitt Lymphoma

20. Discovery and Validation of Cell-Surface Protein Mesothelin (MSLN) As a Novel Therapeutic Target in AML: Results from the COG/NCI Target AML Initiative

21. ASXL1 and ASXL2 Mutations in Childhood AML Are Strongly Associated with t(8;21) but Do Not Independently Impact on Prognosis: A Report from the Children's Oncology Group and NCI/COG Target Initiative

22. TET2 Mutations Are Highly Associated with RUNX1-RUNX1T1 Translocations and NPMc+ in Childhood AML: a Report from Children's Oncology Group AAML03P1, AAML0531 and NCI/COG Target AML Initiative

23. Comprehensive Sequence Analysis of Relapse and Refractory Pediatric Acute Myeloid Leukemia Identifies miRNA and mRNA Transcripts Associated with Treatment Resistance - a Report from the COG/NCI-Target AML Initiative

24. CSF3R Mutations Represent a Novel Therapeutic Target in Pediatric AML with a High Degree of Overlap with CEBPA Mutations: a Report from COG AAML0531 and COG/NCI Target AML Initiative

25. Comprehensive Genomic and Transcript Profiling of CBL Gene in Childhood AML: A Report from Children's Oncology Group Studies AAML03P1, AAML0531 and COG/NCI Target AML Initiative

26. Discovery and Functional Validation of Novel Pediatric Specific FLT3 Activating Mutations in Acute Myeloid Leukemia: Results from the COG/NCI Target Initiative

Catalog

Books, media, physical & digital resources